Learning and Education to ADvance and Empower Rare Disease Drug Developers (LEADER 3D)

Summary

FDA's CDER Rare Diseases Team launched LEADER 3D, an educational initiative to advance rare disease drug development as part of the Accelerating Rare disease Cures (ARC) Program.